Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
- Prat, A.
- Guarneri, V.
- Pascual, T.
- Brasó-Maristany, F.
- Sanfeliu, E.
- Paré, L.
- Schettini, F.
- Martínez, D.
- Jares, P.
- Griguolo, G.
- Dieci, M.V.
- Cortés, J.
- Llombart-Cussac, A.
- Conte, B.
- Marín-Aguilera, M.
- Chic, N.
- Puig-Butillé, J.A.
- Martínez, A.
- Galván, P.
- Tsai, Y.-H.
- González-Farré, B.
- Mira, A.
- Vivancos, A.
- Villagrasa, P.
- Parker, J.S.
- Conte, P.
- Perou, C.M.
- Erakutsi egile guztiak +
Aldizkaria:
eBioMedicine
ISSN: 2352-3964
Argitalpen urtea: 2022
Alea: 75
Mota: Artikulua